Supplementation of Maternal Diets during Pregnancy and for 6 Months Postpartum and Infant Diets Thereafter with Small-Quantity Lipid-Based Nutrient Supplements Does Not Promote Child Growth by 18 Months of Age in Rural Malawi: A Randomized Controlled Trial

J Nutr. 2015 Jun;145(6):1345-53. doi: 10.3945/jn.114.207225. Epub 2015 Apr 29.

Abstract

Background: Intrauterine growth restriction may be reduced by supplementing maternal diets during pregnancy, but few studies have assessed the impact of combined prenatal and postnatal interventions on child growth.

Objective: We tested a hypothesis that provision of small-quantity lipid-based nutrient supplements (SQ-LNSs) to mothers in pregnancy and 6 mo postpartum and to their infants from 6 to 18 mo of age would promote infant and child growth in the study area in rural Malawi.

Methods: We enrolled 869 pregnant women in a randomized trial in Malawi. During pregnancy and 6 mo thereafter, the women received daily 1 capsule of iron-folic acid (IFA), 1 capsule containing 18 micronutrients (MMN), or one 20-g sachet of SQ-LNS [lipid-based nutrient supplements (LNS), containing 21 MMN, protein, carbohydrates, essential fatty acids, and 118 kcal]. Children in the IFA and MMN groups received no supplementation; children in the LNS group received SQ-LNSs from 6 to 18 mo. Primary outcome was child length at 18 mo.

Results: At 18 mo, the mean length in the IFA, MMN, and LNS groups was 77.0, 76.9, and 76.8 cm (P = 0.90), respectively, and the prevalence of stunting was 32.7%, 35.6%, and 37.9% (P = 0.54), respectively. No intergroup differences were found in the mean weight, head circumference, or midupper arm circumference or the proportions with low z scores for these variables (P > 0.05). Covariate adjustment did not change the analysis results, and the associations between the intervention and child length were not modified by maternal parity, age, or nutritional status (P > 0.10).

Conclusions: The findings do not support a hypothesis that provision of SQ-LNSs to women in pregnancy and postpartum and to children from 6 to 18 mo of age would promote child growth in this Malawian study area. This trial was registered at clinicaltrials.gov as NCT01239693.

Keywords: LNS; Sub-Saharan Africa; dietary supplementation; infant; linear growth failure; postnatal intervention; prenatal intervention; stunting.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Body Weight
  • Child Development*
  • Dietary Carbohydrates / administration & dosage
  • Dietary Proteins / administration & dosage
  • Dietary Supplements*
  • Energy Intake
  • Fatty Acids, Essential / administration & dosage
  • Female
  • Folic Acid / administration & dosage
  • Follow-Up Studies
  • Growth Charts
  • Humans
  • Infant
  • Infant Nutritional Physiological Phenomena*
  • Iron, Dietary / administration & dosage
  • Malawi
  • Maternal Nutritional Physiological Phenomena*
  • Micronutrients / administration & dosage
  • Nutritional Status
  • Parity
  • Postpartum Period
  • Pregnancy
  • Rural Population

Substances

  • Dietary Carbohydrates
  • Dietary Proteins
  • Fatty Acids, Essential
  • Iron, Dietary
  • Micronutrients
  • Folic Acid

Associated data

  • ClinicalTrials.gov/NCT01239693